Xense

Xense

San Francisco, CA
MINORITY FOUNDERS WOMEN FOUNDERS SOCIAL IMPACT
Express Interest

Xense, with a valuation of $99.9 million, is raising funds on StartEngine. The company has developed a revolutionary imaging platform called uTomo that provides MetaCT. uTomo combines plain X-ray and CT scanning to diagnose patients with life-threatening problems at a more rapid rate. MetaCT provided by uTomo is user-friendly, eco-friendly, and provides advanced high-resolution 2D and 3D CT images. Ying Zhao founded Xense in April 2018. The current crowdfunding campaign has a minimum target of $14,999.87 and a maximum target of $617,993.97. The campaign proceeds will be used for marketing, research and development, company employment, working capital, inventory, and operations.

Xense, with a valuation of $99.9 million, is raising funds on StartEngine. The company has developed a revolutionary imaging platform called uTomo that provides MetaCT. uTomo combines plain X-ray and CT scanning to diagnose patients with life-threatening problems at a more rapid rate. MetaCT provided by uTomo is user-friendly, eco-friendly, and provides advanced high-resolution 2D and 3D CT images. Ying Zhao founded Xense in April 2018. The current crowdfunding campaign has a minimum target of $14,999.87 and a maximum target of $617,993.97. The campaign proceeds will be used for marketing, research and development, company employment, working capital, inventory, and operations.

Stay in the Loop

Get updates from Xense

Get exclusive updates from Xense

Be the first to know about company milestones, news, and opportunities.

🔒 No spam. Just real progress.

Company Stats

Key metrics about Xense

Industry Healthcare & Pharmaceuticals

Are you the owner of Xense?

Claim your company profile to respond to reviews, update your information, and connect with investors.

Claim This Company

We use cookies on this site to enhance your user experience and analyze site traffic. By clicking "Accept", you consent to our use of cookies. Learn more